8E40.0 Neoplastic meningitis International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Inflammation of the meninges due to malignant infiltration from carcinomas, leukaemias and lymphomas. The syndrome is clinically characterised by headache, neck stiffness, fever and photophobia with potential progression to stupor and coma. The presentation may be acute, subacute or chronic. Diagnosis may be aided by neuroimaging and spinal fluid analysis which may reveal a lymphocytic pleocytosis, raised protein and the presence of malignant cells on cytology.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Specific anatomy - multiple selections are allowed [select] XA6HA2 Cerebral meninges – XA9M51 Cranial dura mater – XA6WL2 Cranial arachnoid – XA2T81 Cranial pia mater – XA7N98 Tentorium cerebelli – XA09H1 Falx without further specification –– XA1FV7 Falx cerebri –– XA33G9 Falx cerebelli XA5AH0 Spinal meninges – XA8R98 Spinal dura mater – XA0382 Spinal arachnoid – XA8SH5 Spinal pia mater Has causing condition - a selection is required - multiple selections are allowed [select] 2A00 Primary neoplasms of brain – 2A00.0 Gliomas of brain – 2A00.1 Embryonal tumours of brain – 2A00.2 Tumours of neuroepithelial tissue of brain – 2A00.3 Central neurocytoma of brain – 2A00.4 Astroblastoma of the brain – 2A00.5 Primary neoplasm of brain of unknown or unspecified type –– 2A00.00 Glioblastoma of brain –– 2A00.0Y Other specified gliomas of brain –– 2A00.0Z Gliomas of brain, unspecified –– 2A00.10 Medulloblastoma of brain –– 2A00.11 Central primitive neuroectodermal tumour –– 2A00.1Y Other specified embryonal tumours of brain –– 2A00.1Z Embryonal tumours of brain, unspecified –– 2A00.20 Tumours of the pineal gland or pineal region –– 2A00.21 Mixed neuronal-glial tumours –– 2A00.22 Choroid plexus tumours –– 2A00.2Y Other specified tumours of neuroepithelial tissue of brain –– 2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified 2A01 Primary neoplasms of meninges – 2A01.0 Meningiomas – 2A01.1 Mesenchymal tumours of meninges – 2A01.2 Primary neoplasm of meninges of unknown or unspecified type –– 2A01.00 Primary malignant meningioma –– 2A01.0Y Other specified meningiomas –– 2A01.0Z Meningiomas, unspecified 2A02 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system – 2A02.0 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system – 2A02.1 Tumours of cranial or paraspinal nerves – 2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type – 2A02.3 Benign neoplasm of cranial nerves – 2A02.4 Benign neoplasm of spinal cord –– 2A02.00 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system –– 2A02.0Y Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system –– 2A02.0Z Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified –– 2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves –– 2A02.11 Paraspinal neuroblastoma –– 2A02.12 Malignant neoplasm of the optic nerve –– 2A02.1Y Other specified tumours of cranial or paraspinal nerves –– 2A02.1Z Tumours of cranial or paraspinal nerves, unspecified 2A0Z Other and unspecified neoplasms of brain or central nervous system – 2A20 Non mast cell myeloproliferative neoplasms –– 2A20.0 Chronic myelogenous leukaemia, BCR-ABL1-positive –– 2A20.1 Chronic neutrophilic leukaemia –– 2A20.2 Primary myelofibrosis –– 2A20.3 Chronic eosinophilic leukaemia, not elsewhere classified –– 2A20.4 Polycythaemia vera –– 2A20.5 Non mast cell myeloproliferative neoplasm, unclassifiable –– 2A20.Y Other specified non mast cell myeloproliferative neoplasms –– 2A20.Z Non mast cell myeloproliferative neoplasms, unspecified ––– 2A20.00 Chronic myelogenous leukaemia with blast crisis ––– 2A20.01 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive ––– 2A20.02 Chronic myelogenous leukaemia, t(9:22)(q34; q11) ––– 2A20.03 Naegeli-type monocytic leukaemia ––– 2A20.0Y Other specified chronic myelogenous leukaemia, BCR-ABL1-positive ––– 2A20.0Z Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified – 2A21 Mastocytosis –– 2A21.0 Systemic mastocytosis –– 2A21.1 Cutaneous mastocytosis –– 2A21.2 Mast cell sarcoma –– 2A21.3 Extracutaneous mastocytoma –– 2A21.Y Other specified mastocytosis –– 2A21.Z Mastocytosis, unspecified ––– 2A21.00 Mast cell leukaemia ––– 2A21.0Y Other specified systemic mastocytosis ––– 2A21.0Z Systemic mastocytosis, unspecified ––– 2A21.10 Urticaria pigmentosa ––– 2A21.1Y Other specified cutaneous mastocytosis ––– 2A21.1Z Cutaneous mastocytosis, unspecified – 2A22 Other and unspecified myeloproliferative neoplasms – 2A30 Refractory anaemia – 2A31 Refractory neutropaenia – 2A32 Refractory thrombocytopenia – 2A33 Refractory anaemia with ring sideroblasts – 2A34 Refractory cytopenia with multi-lineage dysplasia – 2A35 Refractory anaemia with excess of blasts – 2A36 Myelodysplastic syndrome with isolated del(5q) – 2A37 Myelodysplastic syndrome, unclassifiable – 2A38 Refractory cytopenia of childhood – 2A3Y Other specified myelodysplastic syndromes – 2A3Z Myelodysplastic syndromes, unspecified – 2A40 Chronic myelomonocytic leukaemia – 2A41 Atypical chronic myeloid leukaemia, BCR-ABL1-negative – 2A42 Juvenile myelomonocytic leukaemia –– 2A42.0 Juvenile myelomonocytic leukaemia in complete remission –– 2A42.Y Other specified juvenile myelomonocytic leukaemia –– 2A42.Z Juvenile myelomonocytic leukaemia, unspecified – 2A43 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis – 2A44 Myeloproliferative and myelodysplastic disease, unclassifiable – 2A4Y Other specified myelodysplastic and myeloproliferative neoplasms – 2A4Z Myelodysplastic and myeloproliferative neoplasms, unspecified – 2A50 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement – 2A51 Myeloid neoplasm associated with PDGFRB rearrangement – 2A52 Myeloid or lymphoid neoplasms with FGFR1 abnormalities – 2A5Z Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified 2A60 Acute myeloid leukaemias and related precursor neoplasms – 2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities – 2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes – 2A60.2 Therapy-related myeloid neoplasms – 2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types – 2A60.4 Myeloid proliferation associated with Down syndrome – 2A60.5 Blastic plasmacytoid dendritic cell neoplasm – 2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms – 2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified –– 2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome –– 2A60.2Y Other specified therapy-related myeloid neoplasms –– 2A60.2Z Therapy-related myeloid neoplasms, unspecified –– 2A60.30 Acute myeloid leukaemia with minimal differentiation –– 2A60.31 Acute myeloid leukaemia without maturation –– 2A60.32 Acute myeloid leukaemia with maturation –– 2A60.33 Acute myelomonocytic leukaemia –– 2A60.34 Acute monoblastic or monocytic leukaemia –– 2A60.35 Acute erythroid leukaemia –– 2A60.36 Acute megakaryoblastic leukaemia –– 2A60.37 Acute basophilic leukaemia –– 2A60.38 Acute panmyelosis with myelofibrosis –– 2A60.39 Myeloid sarcoma –– 2A60.3Y Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types –– 2A60.3Z Acute myeloid leukaemia, unspecified –– 2A60.40 Transient abnormal myelopoiesis –– 2A60.41 Myeloid leukaemia associated with Down syndrome –– 2A60.4Y Other specified myeloid proliferation associated with Down syndrome –– 2A60.4Z Myeloid proliferation associated with Down syndrome, unspecified 2A61 Acute leukaemias of ambiguous lineage – 2A70 Precursor B-lymphoblastic neoplasms –– 2A70.0 B lymphoblastic leukaemia or lymphoma, not elsewhere classified –– 2A70.1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 –– 2A70.Y Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities – 2A71 Precursor T-lymphoblastic neoplasms – 2A7Z Precursor lymphoid neoplasms, unspecified – 2A80 Follicular lymphoma –– 2A80.0 Follicular lymphoma grade 1 –– 2A80.1 Follicular lymphoma grade 2 –– 2A80.2 Follicular lymphoma grade 3 –– 2A80.3 Primary cutaneous follicle centre lymphoma –– 2A80.4 Paediatric type follicular lymphoma –– 2A80.5 Follicular lymphoma in situ –– 2A80.6 Follicular lymphoma of small intestine –– 2A80.Y Other specified follicular lymphoma –– 2A80.Z Follicular lymphoma, unspecified – 2A81 Diffuse large B-cell lymphomas –– 2A81.0 Primary mediastinal large B-cell lymphoma –– 2A81.1 Intravascular large B-cell lymphoma –– 2A81.2 Plasmablastic lymphoma –– 2A81.3 Lymphomatoid granulomatosis –– 2A81.4 T-cell/histiocyte rich large B-cell lymphoma –– 2A81.5 Primary diffuse large B-cell lymphoma of central nervous system –– 2A81.6 Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly –– 2A81.7 Diffuse large B-cell lymphoma associated with chronic inflammation –– 2A81.8 ALK-positive large B-cell lymphoma –– 2A81.9 Primary effusion lymphoma –– 2A81.A Primary cutaneous diffuse large B-cell lymphoma, leg type –– 2A81.Y Other specified diffuse large B-cell lymphomas –– 2A81.Z Diffuse large B-cell lymphoma, not otherwise specified – 2A82 Mature B-cell neoplasm with leukaemic behaviour –– 2A82.0 Chronic lymphocytic leukaemia or small lymphocytic lymphoma –– 2A82.1 B-cell prolymphocytic leukaemia –– 2A82.2 Hairy-cell leukaemia –– 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable –– 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour –– 2A82.Z Mature B-cell neoplasm with leukaemic behaviour, unspecified ––– 2A82.00 Chronic lymphocytic leukaemia of B-cell type ––– 2A82.0Y Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma ––– 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified ––– 2A82.10 B-cell prolymphocytic leukaemia in complete remission ––– 2A82.1Y Other specified b-cell prolymphocytic leukaemia ––– 2A82.1Z B-cell prolymphocytic leukaemia, unspecified – 2A83 Plasma cell neoplasms –– 2A83.0 Monoclonal gammopathy of undetermined significance –– 2A83.1 Plasma cell myeloma –– 2A83.2 Solitary plasmacytoma –– 2A83.3 Extraosseous plasmacytoma –– 2A83.4 Plasma cell leukaemia –– 2A83.5 Monoclonal immunoglobulin deposition disease –– 2A83.Y Other specified multiple myeloma and plasma cell neoplasms –– 2A83.Z Plasma cell neoplasm, unspecified ––– 2A83.50 Heavy chain deposition disease ––– 2A83.51 Light and heavy chain deposition disease ––– 2A83.52 Light chain deposition disease – 2A84 Heavy chain diseases or malignant immunoproliferative diseases –– 2A84.0 Alpha heavy chain disease –– 2A84.1 Gamma heavy chain disease –– 2A84.2 Mu heavy chain disease –– 2A84.Y Other specified malignant immunoproliferative diseases –– 2A84.Z Heavy chain diseases, unspecified – 2A85 Other specified mature B-cell neoplasms or lymphoma –– 2A85.0 Nodal marginal zone lymphoma –– 2A85.1 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach –– 2A85.2 Extranodal marginal zone B-cell lymphoma, primary site skin –– 2A85.3 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin –– 2A85.4 Lymphoplasmacytic lymphoma –– 2A85.5 Mantle cell lymphoma –– 2A85.6 Burkitt lymphoma including Burkitt leukaemia –– 2A85.Y Further specified mature B-cell neoplasms or lymphoma – 2A86 B-cell lymphoma, mixed features –– 2A86.0 Malignant lymphoma of B cell type, not elsewhere classified –– 2A86.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma –– 2A86.2 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma –– 2A86.Y Other specified B-cell lymphoma, mixed features –– 2A86.Z B-cell lymphoma, mixed features, unspecified – 2A8Z Mature B-cell neoplasms, unspecified – 2A90 Mature T-cell lymphoma, specified types, nodal or systemic –– 2A90.0 T-cell prolymphocytic leukaemia –– 2A90.1 T-cell large granular lymphocytic leukaemia –– 2A90.2 Chronic lymphoproliferative disorders of NK-cells –– 2A90.3 Aggressive NK cell leukaemia –– 2A90.4 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood –– 2A90.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated –– 2A90.6 Extranodal NK/T-cell lymphoma, nasal type –– 2A90.7 Enteropathy associated T-cell lymphoma –– 2A90.8 Hepatosplenic T-cell lymphoma –– 2A90.9 Angioimmunoblastic T-cell lymphoma –– 2A90.A Anaplastic large cell lymphoma, ALK-positive –– 2A90.B Anaplastic large cell lymphoma, ALK-negative –– 2A90.C Peripheral T-cell lymphoma, not otherwise specified –– 2B00 Subcutaneous panniculitis-like T-cell lymphoma –– 2B01 Mycosis fungoides –– 2B02 Sézary syndrome –– 2B03 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders ––– 2B03.0 Primary cutaneous CD30-positive anaplastic large cell lymphoma ––– 2B03.1 Lymphomatoid papulosis –– 2B0Y Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders –– 2B0Z Primary cutaneous T-cell lymphoma of undetermined or unspecified type – 2B2Y Other specified mature T-cell or NK-cell neoplasms – 2B2Z Mature T-cell or NK-cell neoplasms, unspecified 2B30 Hodgkin lymphoma – 2B30.0 Nodular lymphocyte predominant Hodgkin lymphoma – 2B30.1 Classical Hodgkin lymphoma – 2B30.Z Hodgkin lymphoma, unspecified –– 2B30.10 Nodular sclerosis classical Hodgkin lymphoma –– 2B30.11 Lymphocyte-rich classical Hodgkin lymphoma –– 2B30.12 Mixed cellularity classical Hodgkin lymphoma –– 2B30.13 Lymphocyte depleted classical Hodgkin lymphoma –– 2B30.1Z Classical Hodgkin lymphoma, unspecified 2B31 Histiocytic or dendritic cell neoplasms – 2B31.0 Juvenile xanthogranuloma – 2B31.1 Histiocytic sarcoma – 2B31.2 Langerhans cell histiocytosis – 2B31.3 Langerhans cell sarcoma – 2B31.4 Interdigitating dendritic cell sarcoma – 2B31.5 Follicular dendritic cell sarcoma – 2B31.6 Indeterminate cell histiocytosis – 2B31.7 Fibroblastic reticular cell tumour – 2B31.Y Other specified histiocytic or dendritic cell neoplasms – 2B31.Z Histiocytic or dendritic cell neoplasms, unspecified –– 2B31.20 Langerhans cell histiocytosis involving the skin –– 2B31.2Y Other specified Langerhans cell histiocytosis –– 2B31.2Z Langerhans cell histiocytosis, unspecified 2B32 Immunodeficiency-associated lymphoproliferative disorders – 2B32.0 Post-transplant lymphoproliferative disorder, early lesion – 2B32.1 Reactive plasmacytic hyperplasia – 2B32.2 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like – 2B32.3 Polymorphic post-transplant lymphoproliferative disorder – 2B32.Y Other specified immunodeficiency-associated lymphoproliferative disorders – 2B32.Z Immunodeficiency-associated lymphoproliferative disorders, unspecified 2B33 Malignant haematopoietic neoplasms without further specification – 2B33.0 Acute leukaemia, not elsewhere classified – 2B33.1 Myeloid leukaemia – 2B33.2 Chronic myeloid leukaemia, not elsewhere classified – 2B33.3 Lymphoid leukaemia, not elsewhere classified – 2B33.4 Leukaemia, unspecified – 2B33.5 Malignant lymphoma, not elsewhere classified – 2B33.Y Other malignant haematopoietic neoplasms without further specification 2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified –– 2B50 Chondrosarcoma, primary site ––– 2B50.0 Chondrosarcoma of bone or articular cartilage of limbs ––– 2B50.1 Chondrosarcoma of bone or articular cartilage of pelvis ––– 2B50.2 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle ––– 2B50.Y Chondrosarcoma of bone or articular cartilage of other specified sites ––– 2B50.Z Chondrosarcoma of bone or articular cartilage of unspecified sites –– 2B51 Osteosarcoma, primary site ––– 2B51.0 Osteosarcoma of bone or articular cartilage of jaw ––– 2B51.1 Osteosarcoma of bone or articular cartilage of limbs ––– 2B51.2 Osteosarcoma of bone or articular cartilage of pelvis ––– 2B51.Y Osteosarcoma of bone and articular cartilage of other specified sites ––– 2B51.Z Osteosarcoma of bone and articular cartilage of unspecified sites –– 2B52 Ewing sarcoma, primary site ––– 2B52.0 Ewing sarcoma of bone or articular cartilage of limbs ––– 2B52.1 Ewing sarcoma of bone or articular cartilage of pelvis ––– 2B52.2 Ewing sarcoma of bone or articular cartilage of ribs ––– 2B52.3 Ewing sarcoma of soft tissue ––– 2B52.Y Ewing sarcoma of bone and articular cartilage of other specified sites ––– 2B52.Z Ewing sarcoma of bone and articular cartilage of unspecified sites –– 2B53 Fibroblastic or myofibroblastic tumour, primary site ––– 2B53.0 Myxofibrosarcoma, primary site ––– 2B53.1 Fibroblastic or myofibroblastic tumour of skin ––– 2B53.Y Other specified fibroblastic or myofibroblastic tumour, primary site ––– 2B53.Z Fibroblastic or myofibroblastic tumour, primary site, unspecified –– 2B54 Unclassified pleomorphic sarcoma, primary site ––– 2B54.0 Unclassified pleomorphic sarcoma of skin ––– 2B54.1 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum ––– 2B54.Y Unclassified pleomorphic sarcoma, primary site, other specified site ––– 2B54.Z Unclassified pleomorphic sarcoma, primary site, unspecified site –– 2B55 Rhabdomyosarcoma, primary site ––– 2B55.0 Rhabdomyosarcoma of the oral cavity or pharynx ––– 2B55.1 Rhabdomyosarcoma of respiratory or intrathoracic organs ––– 2B55.2 Rhabdomyosarcoma of male genital organs ––– 2B55.Y Rhabdomyosarcoma, other specified primary site ––– 2B55.Z Rhabdomyosarcoma, unspecified primary site –– 2B56 Angiosarcoma, primary site ––– 2B56.0 Angiosarcoma of heart ––– 2B56.1 Angiosarcoma of skin ––– 2B56.2 Angiosarcoma of breast ––– 2B56.3 Angiosarcoma of liver ––– 2B56.Y Angiosarcoma, other specified primary site ––– 2B56.Z Angiosarcoma, unspecified primary site –– 2B57 Kaposi sarcoma, primary site ––– 2B57.0 Kaposi sarcoma of lung ––– 2B57.1 Kaposi sarcoma of skin ––– 2B57.2 Kaposi sarcoma of gastrointestinal sites ––– 2B57.Y Kaposi sarcoma of other specified primary sites ––– 2B57.Z Kaposi sarcoma of unspecified primary site –– 2B58 Leiomyosarcoma, primary site ––– 2B58.0 Leiomyosarcoma of retroperitoneum or peritoneum ––– 2B58.1 Leiomyosarcoma of uterus ––– 2B58.2 Leiomyosarcoma of stomach ––– 2B58.Y Leiomyosarcoma, other specified primary site ––– 2B58.Z Leiomyosarcoma, unspecified primary site –– 2B59 Liposarcoma, primary site ––– 2B59.0 Liposarcoma of soft tissue of limb ––– 2B59.1 Liposarcoma of retroperitoneum or peritoneum ––– 2B59.2 Liposarcoma of male genital organs ––– 2B59.Y Liposarcoma, other specified primary site ––– 2B59.Z Liposarcoma, unspecified primary site –– 2B5A Synovial sarcoma, primary site ––– 2B5A.0 Synovial sarcoma of soft tissues of limb ––– 2B5A.1 Synovial sarcoma of respiratory or intra-thoracic organs ––– 2B5A.Y Synovial sarcoma, other specified primary site ––– 2B5A.Z Synovial sarcoma, unspecified primary site –– 2B5B Gastrointestinal stromal tumour, primary site ––– 2B5B.0 Gastrointestinal stromal tumour of stomach ––– 2B5B.1 Gastrointestinal stromal tumour of small intestine ––– 2B5B.Y Gastrointestinal stromal tumour of other gastrointestinal sites ––– 2B5B.Z Gastrointestinal stromal tumour of unspecified gastrointestinal sites –– 2B5C Endometrial stromal sarcoma, primary site –– 2B5D Malignant mixed epithelial mesenchymal tumour, primary site ––– 2B5D.0 Malignant mixed epithelial mesenchymal tumour of ovary ––– 2B5D.1 Malignant mixed epithelial and mesenchymal tumour of corpus uteri ––– 2B5D.Y Malignant mixed epithelial mesenchymal tumour, other specified primary site ––– 2B5D.Z Malignant mixed epithelial mesenchymal tumour, unspecified primary site –– 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site –– 2B5F Sarcoma, not elsewhere classified, primary site ––– 2B5F.0 Sarcoma, not elsewhere classified of uterus ––– 2B5F.1 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum ––– 2B5F.2 Sarcoma, not elsewhere classified of other specified sites ––– 2B5F.3 Sarcoma, not elsewhere classified, primary site unknown –––– 2B5F.10 Myosarcomas of omentum –––– 2B5F.1Y Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum –––– 2B5F.1Z Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified –– 2B5G Myosarcoma of uterus, part not specified –– 2B5H Well differentiated lipomatous tumour, primary site –– 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites –– 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites –– 2B5Y Other specified malignant mesenchymal neoplasms –– 2B5Z Malignant mesenchymal neoplasm of unspecified type –– 2B60 Malignant neoplasms of lip ––– 2B60.0 Basal cell carcinoma of lip ––– 2B60.1 Squamous cell carcinoma of lip ––– 2B60.Y Other specified malignant neoplasms of lip ––– 2B60.Z Malignant neoplasms of lip, unspecified –– 2B61 Malignant neoplasms of base of tongue ––– 2B61.0 Squamous cell carcinoma of the base of the tongue ––– 2B61.Y Other specified malignant neoplasms of base of tongue ––– 2B61.Z Malignant neoplasms of base of tongue, unspecified –– 2B62 Malignant neoplasms of other or unspecified parts of tongue ––– 2B62.0 Squamous cell carcinoma of other or unspecified parts of tongue ––– 2B62.1 Malignant neoplasms of lingual tonsil ––– 2B62.Y Other specified malignant neoplasms of other and unspecified parts of tongue ––– 2B62.Z Malignant neoplasms of other or unspecified parts of tongue, unspecified –––– 2B62.10 Squamous cell carcinoma of lingual tonsil –––– 2B62.1Z Malignant neoplasms of lingual tonsil, unspecified –– 2B63 Malignant neoplasms of gum ––– 2B63.0 Squamous cell carcinoma of gum ––– 2B63.Y Other specified malignant neoplasm of gum ––– 2B63.Z Malignant neoplasms of gum, unspecified –– 2B64 Malignant neoplasms of floor of mouth ––– 2B64.0 Squamous cell carcinoma of floor of mouth ––– 2B64.Y Other specified malignant neoplasm of floor of mouth ––– 2B64.Z Malignant neoplasms of floor of mouth, unspecified –– 2B65 Malignant neoplasms of palate ––– 2B65.0 Adenocarcinoma of palate ––– 2B65.1 Squamous cell carcinoma of palate ––– 2B65.Y Other specified malignant neoplasm of palate ––– 2B65.Z Malignant neoplasms of palate, unspecified –– 2B66 Malignant neoplasms of other or unspecified parts of mouth ––– 2B66.0 Squamous cell carcinoma of other or unspecified parts of mouth ––– 2B66.Y Other specified malignant neoplasms of other and unspecified parts of mouth ––– 2B66.Z Malignant neoplasms of other or unspecified parts of mouth, unspecified –– 2B67 Malignant neoplasms of parotid gland ––– 2B67.0 Adenocarcinoma of parotid gland ––– 2B67.1 Squamous cell carcinoma of parotid gland ––– 2B67.Y Other specified malignant neoplasms of parotid gland ––– 2B67.Z Malignant neoplasms of parotid gland, unspecified –– 2B68 Malignant neoplasms of submandibular or sublingual glands ––– 2B68.0 Adenocarcinoma of submandibular or sublingual glands ––– 2B68.1 Squamous cell carcinoma of submandibular or sublingual glands ––– 2B68.2 Other specified malignant neoplasms of submandibular or sublingual glands ––– 2B68.Z Malignant neoplasms of submandibular or sublingual glands, unspecified –– 2B69 Malignant neoplasms of tonsil ––– 2B69.0 Squamous cell carcinoma of tonsil ––– 2B69.1 Other specified malignant neoplasms of tonsil ––– 2B69.Z Malignant neoplasms of tonsil, unspecified –– 2B6A Malignant neoplasms of oropharynx ––– 2B6A.0 Squamous cell carcinoma of oropharynx ––– 2B6A.Y Other specified malignant neoplasms of oropharynx ––– 2B6A.Z Malignant neoplasms of oropharynx, unspecified –– 2B6B Malignant neoplasms of nasopharynx ––– 2B6B.0 Squamous cell carcinoma of nasopharynx ––– 2B6B.1 Malignant epithelial neoplasms of nasopharynx, unspecified type ––– 2B6B.2 Malignant neoplasms of pharyngeal tonsil ––– 2B6B.Y Other specified malignant neoplasms of nasopharynx ––– 2B6B.Z Malignant neoplasms of nasopharynx, unspecified –––– 2B6B.20 Squamous cell carcinoma of pharyngeal tonsil –––– 2B6B.21 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil –––– 2B6B.2Y Other specified malignant neoplasms of pharyngeal tonsil –––– 2B6B.2Z Malignant neoplasm of pharyngeal tonsil without mention of type –– 2B6C Malignant neoplasms of piriform sinus ––– 2B6C.0 Squamous cell carcinoma of piriform sinus ––– 2B6C.Y Other specified malignant neoplasms of piriform sinus ––– 2B6C.Z Malignant neoplasms of piriform sinus, unspecified –– 2B6D Malignant neoplasms of hypopharynx ––– 2B6D.0 Squamous cell carcinoma of hypopharynx and variants ––– 2B6D.Y Other specified malignant neoplasms of hypopharynx ––– 2B6D.Z Malignant neoplasms of hypopharynx, unspecified –– 2B6E Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.0 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Y Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Z Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified –– 2B6Y Other specified malignant neoplasms of lip, oral cavity or pharynx –– 2B70 Malignant neoplasms of oesophagus ––– 2B70.0 Adenocarcinoma of oesophagus ––– 2B70.1 Squamous cell carcinoma of oesophagus ––– 2B70.Y Other specified malignant neoplasms of oesophagus ––– 2B70.Z Malignant neoplasms of oesophagus, unspecified –––– 2B70.00 Barrett adenocarcinoma –––– 2B70.0Y Other specified adenocarcinoma of oesophagus –––– 2B70.0Z Adenocarcinoma of oesophagus, unspecified –– 2B71 Malignant neoplasms of oesophagogastric junction ––– 2B71.0 Adenocarcinoma of oesophagogastric junction ––– 2B71.Y Other specified malignant neoplasm of oesophagogastric junction ––– 2B71.Z Malignant neoplasms of oesophagogastric junction, unspecified –– 2B72 Malignant neoplasms of stomach ––– 2B72.0 Adenocarcinoma of stomach ––– 2B72.1 Malignant neuroendocrine neoplasm of stomach ––– 2B72.Y Other specified malignant neoplasms of stomach ––– 2B72.Z Malignant neoplasms of stomach, unspecified ––– 2B80 Malignant neoplasms of small intestine –––– 2B80.0 Malignant neoplasms of duodenum –––– 2B80.1 Malignant neoplasms of jejunum or ileum –––– 2B80.2 Malignant neoplasms of small intestine, site unspecified –––– 2B80.Y Other specified malignant neoplasms of small intestine –––– 2B80.Z Malignant neoplasms of small intestine, unspecified ––––– 2B80.00 Adenocarcinoma of duodenum ––––– 2B80.01 Neuroendocrine neoplasm of duodenum ––––– 2B80.0Y Other specified malignant neoplasms of the duodenum ––––– 2B80.0Z Malignant neoplasms of duodenum, unspecified ––––– 2B80.10 Adenocarcinoma of jejunum or ileum ––––– 2B80.11 Neuroendocrine neoplasms of jejunum or ileum ––––– 2B80.1Y Other specified malignant neoplasms of jejunum or ileum ––––– 2B80.1Z Malignant neoplasms of jejunum or ileum, unspecified ––––– 2B80.20 Adenocarcinoma of small intestine, site unspecified ––––– 2B80.21 Neuroendocrine neoplasms of small intestine, site unspecified ––––– 2B80.2Y Other specified malignant neoplasms of small intestine, site unspecified ––– 2B81 Malignant neoplasms of appendix –––– 2B81.0 Adenocarcinoma of appendix –––– 2B81.2 Neuroendocrine neoplasms of appendix –––– 2B81.Y Other specified malignant neoplasms of appendix –––– 2B81.Z Malignant neoplasms of appendix, unspecified ––––– 2B81.00 Mucinous adenocarcinoma of appendix –––– 2B90 Malignant neoplasms of colon ––––– 2B90.0 Malignant neoplasm of ascending colon and right flexure of colon ––––– 2B90.1 Malignant neoplasm of descending colon and splenic flexure of colon ––––– 2B90.2 Malignant neoplasm of transverse colon ––––– 2B90.3 Malignant neoplasm of sigmoid colon ––––– 2B90.Y Other specified malignant neoplasms of colon ––––– 2B90.Z Malignant neoplasms of colon, unspecified –––––– 2B90.00 Adenocarcinoma of ascending colon or right flexure of colon –––––– 2B90.0Y Other specified malignant neoplasm of ascending colon and right flexure of colon –––––– 2B90.0Z Malignant neoplasm of ascending colon and right flexure of colon, unspecified –––––– 2B90.10 Adenocarcinoma of descending colon or splenic flexure of colon –––––– 2B90.1Y Other specified malignant neoplasm of descending colon and splenic flexure of colon –––––– 2B90.1Z Malignant neoplasm of descending colon and splenic flexure of colon, unspecified –––––– 2B90.20 Adenocarcinoma of transverse colon –––––– 2B90.2Y Other specified malignant neoplasm of transverse colon –––––– 2B90.2Z Malignant neoplasm of transverse colon, unspecified –––––– 2B90.30 Adenocarcinoma of sigmoid colon –––––– 2B90.3Y Other specified malignant neoplasm of sigmoid colon –––––– 2B90.3Z Malignant neoplasm of sigmoid colon, unspecified –––– 2B91 Malignant neoplasms of rectosigmoid junction ––––– 2B91.0 Adenocarcinoma of rectosigmoid junction ––––– 2B91.Y Other specified malignant neoplasms of rectosigmoid junction ––––– 2B91.Z Malignant neoplasms of rectosigmoid junction, unspecified –––– 2B92 Malignant neoplasms of rectum ––––– 2B92.0 Adenocarcinomas of rectum ––––– 2B92.1 Neuroendocrine neoplasms of rectum ––––– 2B92.Y Other specified malignant neoplasms of rectum ––––– 2B92.Z Malignant neoplasms of rectum, unspecified –––– 2B93 Malignant neoplasms of large intestine, site unspecified ––––– 2B93.0 Adenocarcinoma of large intestine, site unspecified ––––– 2B93.Y Other specified malignant neoplasms of large intestine, site unspecified ––––– 2B93.Z Malignant neoplasms of large intestine, site and type unspecified –––– 2B9Y Other specified malignant neoplasms of large intestine ––– 2C00 Malignant neoplasms of anus or anal canal –––– 2C00.0 Adenocarcinoma of anus or anal canal –––– 2C00.1 Melanoma of anus or anal canal –––– 2C00.2 Neuroendocrine neoplasm of anus or anal canal –––– 2C00.3 Squamous cell carcinoma of anus or anal canal –––– 2C00.Y Other specified malignant neoplasms of anus and anal canal –––– 2C00.Z Malignant neoplasms of anus or anal canal, unspecified ––– 2C0Y Other specified malignant neoplasms of intestine ––– 2C0Z Malignant neoplasms of intestine, unspecified –– 2C10 Malignant neoplasm of pancreas ––– 2C10.0 Adenocarcinoma of pancreas ––– 2C10.1 Neuroendocrine neoplasms of pancreas ––– 2C10.Y Other specified malignant neoplasms of pancreas ––– 2C10.Z Malignant neoplasm of pancreas, unspecified –– 2C11 Malignant neoplasms of other or ill-defined digestive organs ––– 2C11.0 Adenocarcinoma of other or ill-defined digestive organs ––– 2C11.1 Mucinous carcinoma of other or ill-defined digestive organs ––– 2C11.2 Other specified malignant neoplasms of other or ill-defined digestive organs ––– 2C11.Z Malignant neoplasms of other or ill-defined digestive organs, unspecified –– 2C12 Malignant neoplasms of liver or intrahepatic bile ducts ––– 2C12.0 Malignant neoplasm of liver ––– 2C12.1 Malignant neoplasm of intrahepatic bile ducts –––– 2C12.00 Combined hepatocellular-cholangiocarcinoma –––– 2C12.01 Hepatoblastoma –––– 2C12.02 Hepatocellular carcinoma of liver –––– 2C12.03 Mesothelial carcinoma of liver –––– 2C12.0Y Other specified malignant neoplasm of liver –––– 2C12.0Z Malignant neoplasm of liver, unspecified –––– 2C12.10 Intrahepatic cholangiocarcinoma –––– 2C12.1Y Other specified malignant neoplasms of intrahepatic bile ducts –––– 2C12.1Z Malignant neoplasm of intrahepatic bile ducts, unspecified –– 2C13 Malignant neoplasms of gallbladder ––– 2C13.0 Adenocarcinoma of the gallbladder ––– 2C13.Y Other specified malignant neoplasm of gallbladder ––– 2C13.Z Malignant neoplasms of gallbladder, unspecified –– 2C14 Malignant neoplasms of proximal biliary tract, cystic duct ––– 2C14.0 Adenocarcinoma of proximal biliary tract, cystic duct ––– 2C14.1 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct ––– 2C14.2 Neuroendocrine neoplasms of cystic duct ––– 2C14.Y Other specified malignant neoplasms of biliary tract, cystic duct ––– 2C14.Z Malignant neoplasms of proximal biliary tract, cystic duct, unspecified –– 2C15 Malignant neoplasms of biliary tract, distal bile duct ––– 2C15.0 Adenocarcinoma of biliary tract, distal bile duct ––– 2C15.1 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct ––– 2C15.2 Neuroendocrine neoplasms of distal bile duct ––– 2C15.Y Other specified malignant neoplasms of biliary tract, distal bile duct ––– 2C15.Z Malignant neoplasms of biliary tract, distal bile duct, unspecified –– 2C16 Malignant neoplasms of ampulla of Vater ––– 2C16.0 Adenocarcinoma of ampulla of Vater ––– 2C16.1 Neuroendocrine neoplasms of ampulla of Vater ––– 2C16.Y Other specified malignant neoplasms of ampulla of Vater ––– 2C16.Z Malignant neoplasms of ampulla of Vater, unspecified –– 2C17 Malignant neoplasms of other or unspecified parts of biliary tract ––– 2C17.0 Adenocarcinoma of other or unspecified parts of biliary tract ––– 2C17.1 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract ––– 2C17.2 Neuroendocrine neoplasms of other or unspecified parts of biliary tract ––– 2C17.Y Other specified malignant neoplasms of overlapping lesion of biliary tract ––– 2C17.Z Malignant neoplasms of other or unspecified parts of biliary tract, unspecified –– 2C18 Malignant neoplasms of perihilar bile duct ––– 2C18.0 Hilar cholangiocarcinoma ––– 2C18.1 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct ––– 2C18.2 Neuroendocrine neoplasm of perihilar bile duct ––– 2C18.Y Other specified malignant neoplasms of perihilar bile duct ––– 2C18.Z Malignant neoplasms of perihilar bile duct, unspecified –– 2C1Z Malignant neoplasms of digestive organs, unspecified –– 2C20 Malignant neoplasms of nasal cavity ––– 2C20.0 Adenocarcinoma of nasal cavity ––– 2C20.1 Malignant neuroepitheliomatous neoplasm of nasal cavity ––– 2C20.2 Melanoma of nasal cavity ––– 2C20.3 Olfactory neuroblastoma ––– 2C20.4 Squamous cell carcinoma of nasal cavity ––– 2C20.Y Other specified malignant neoplasm of nasal cavity ––– 2C20.Z Malignant neoplasms of nasal cavity, unspecified –– 2C21 Malignant neoplasms of middle ear ––– 2C21.0 Adenocarcinoma of middle ear ––– 2C21.1 Squamous cell carcinoma of middle ear ––– 2C21.2 Unspecified malignant epithelial neoplasm of middle ear ––– 2C21.Y Other specified malignant neoplasm of middle ear ––– 2C21.Z Malignant neoplasms of middle ear, unspecified –– 2C22 Malignant neoplasms of accessory sinuses ––– 2C22.0 Adenocarcinoma of accessory sinuses ––– 2C22.1 Squamous cell carcinoma of accessory sinuses ––– 2C22.2 Malignant epithelial neoplasms of accessory sinuses, unspecified type ––– 2C22.3 Melanomas of accessory sinuses ––– 2C22.Y Other specified malignant neoplasms of accessory sinuses ––– 2C22.Z Malignant neoplasms of accessory sinuses, unspecified –––– 2C22.10 Squamous cell carcinoma of sphenoidal sinus –––– 2C22.1Y Squamous cell carcinoma of other specified accessory sinuses –– 2C23 Malignant neoplasms of larynx ––– 2C23.1 Malignant neoplasms of glottis of larynx ––– 2C23.2 Malignant neoplasms of supraglottis of larynx ––– 2C23.3 Malignant neoplasms of subglottis of larynx ––– 2C23.4 Malignant neoplasm of laryngeal cartilage ––– 2C23.5 Malignant neoplasm of overlapping lesion of larynx ––– 2C23.Z Malignant neoplasms of larynx, unspecified –––– 2C23.10 Squamous cell carcinoma of larynx, glottis –––– 2C23.1Y Other specified malignant neoplasms of larynx, glottis –––– 2C23.20 Squamous cell carcinoma of larynx, supraglottis –––– 2C23.2Y Other specified malignant neoplasms of larynx, supraglottis –––– 2C23.30 Squamous cell carcinoma of larynx, subglottis –––– 2C23.31 Adenocarcinoma of larynx, subglottis –––– 2C23.3Y Other specified malignant neoplasms of larynx, subglottis –– 2C24 Malignant neoplasms of trachea ––– 2C24.0 Adenocarcinoma of trachea ––– 2C24.1 Squamous cell carcinoma of trachea ––– 2C24.2 Malignant epithelial neoplasms of trachea, unspecified type ––– 2C24.Y Other specified malignant neoplasms of trachea ––– 2C24.Z Malignant neoplasms of trachea, unspecified –– 2C25 Malignant neoplasms of bronchus or lung ––– 2C25.0 Adenocarcinoma of bronchus or lung ––– 2C25.1 Small cell carcinoma of bronchus or lung ––– 2C25.2 Squamous cell carcinoma of bronchus or lung ––– 2C25.3 Large cell carcinoma of bronchus or lung ––– 2C25.4 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung ––– 2C25.5 Unspecified malignant epithelial neoplasm of bronchus or lung ––– 2C25.Y Other specified malignant neoplasms of bronchus or lung ––– 2C25.Z Malignant neoplasms of bronchus or lung, unspecified –– 2C26 Malignant neoplasms of the pleura ––– 2C26.0 Mesothelioma of pleura ––– 2C26.Y Other specified malignant neoplasms of the pleura ––– 2C26.Z Malignant neoplasms of the pleura, unspecified –– 2C27 Malignant neoplasms of thymus ––– 2C27.0 Carcinoma of thymus ––– 2C27.1 Carcinoid tumour or other neuroendocrine neoplasms of thymus ––– 2C27.2 Malignant thymoma ––– 2C27.Y Other specified malignant neoplasms of thymus ––– 2C27.Z Malignant neoplasms of thymus, unspecified –– 2C28 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.0 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.1 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.Z Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified –– 2C29 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.0 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs ––– 2C29.1 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.Z Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified –– 2C2Y Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs –– 2C2Z Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified –– 2C30 Melanoma of skin ––– 2C30.0 Superficial spreading melanoma, primary ––– 2C30.1 Nodular melanoma, primary ––– 2C30.2 Lentigo maligna melanoma, primary ––– 2C30.3 Acral lentiginous melanoma, primary ––– 2C30.Y Other specified melanoma of skin ––– 2C30.Z Melanoma of skin, unspecified –– 2C31 Squamous cell carcinoma of skin ––– 2C31.0 Verrucous squamous cell carcinoma of skin ––– 2C31.1 Keratoacanthoma ––– 2C31.Z Cutaneous squamous cell carcinoma –– 2C32 Basal cell carcinoma of skin ––– 2C32.0 Nodular basal cell carcinoma of skin ––– 2C32.1 Sclerosing basal cell carcinoma of skin ––– 2C32.2 Superficial basal cell carcinoma of skin ––– 2C32.Y Other specified basal cell carcinoma of skin ––– 2C32.Z Basal cell carcinoma of skin, unspecified –– 2C33 Adnexal carcinoma of skin –– 2C34 Cutaneous neuroendocrine carcinoma –– 2C35 Cutaneous sarcoma –– 2C3Y Other specified malignant neoplasms of skin –– 2C3Z Malignant neoplasm of skin of unknown or unspecified type –– 2C40 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system –– 2C41 Malignant perineurioma –– 2C4Y Other specified malignant neoplasms of peripheral nerves and autonomic nervous system –– 2C4Z Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified –– 2C50 Malignant neoplasms of retroperitoneum ––– 2C50.0 Cystic, mucinous or serous carcinoma of retroperitoneum ––– 2C50.Y Other specified malignant neoplasms of retroperitoneum ––– 2C50.Z Malignant neoplasms of retroperitoneum, unspecified –– 2C51 Malignant neoplasms of peritoneum ––– 2C51.0 Adenocarcinomas of peritoneum ––– 2C51.1 Cystic, mucinous or serous carcinoma of peritoneum ––– 2C51.2 Mesotheliomas of peritoneum ––– 2C51.Y Other specified malignant neoplasms of peritoneum ––– 2C51.Z Malignant neoplasms of peritoneum, unspecified –––– 2C51.20 Mesothelioma of mesocolon –––– 2C51.21 Mesothelioma of mesentery –––– 2C51.2Y Mesotheliomas of other specified sites of peritoneum –––– 2C51.2Z Mesotheliomas of peritoneum, site unspecified –– 2C52 Malignant neoplasms of omentum ––– 2C52.0 Cystic, mucinous or serous carcinoma of omentum ––– 2C52.Y Other specified malignant neoplasms of omentum ––– 2C52.Z Malignant neoplasms of omentum, unspecified –– 2C53 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.0 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.1 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Y Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Z Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified –– 2C5Y Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum –– 2C5Z Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified –– 2C60 Carcinoma of breast, specialised type –– 2C61 Invasive carcinoma of breast ––– 2C61.0 Invasive ductal carcinoma of breast ––– 2C61.1 Invasive lobular carcinoma of breast ––– 2C61.2 Invasive pleomorphic lobular carcinoma of breast ––– 2C61.3 Invasive carcinoma of breast with mixed ductal and lobular features ––– 2C61.4 Invasive carcinoma of breast, unidentifiable type –– 2C62 Inflammatory carcinoma of breast –– 2C63 Malignant phyllodes tumour of breast –– 2C64 Solid papillary carcinoma of breast with evidence of invasion –– 2C65 Hereditary breast and ovarian cancer syndrome –– 2C6Y Other specified malignant neoplasms of breast –– 2C6Z Malignant neoplasms of breast, unspecified –– 2C70 Malignant neoplasms of vulva ––– 2C70.0 Basal cell carcinoma of vulva ––– 2C70.1 Melanoma of vulva ––– 2C70.2 Squamous cell carcinoma of vulva ––– 2C70.Y Other specified malignant neoplasms of vulva ––– 2C70.Z Malignant neoplasms of vulva, unspecified –– 2C71 Malignant neoplasms of vagina ––– 2C71.0 Adenocarcinoma of vagina ––– 2C71.1 Melanoma of vagina ––– 2C71.2 Squamous cell carcinoma of vagina ––– 2C71.Y Other specified malignant neoplasms of vagina ––– 2C71.Z Malignant neoplasms of vagina, unspecified –– 2C72 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa ––– 2C72.0 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.1 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.3 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa ––– 2C72.Y Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa ––– 2C72.Z Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified –– 2C73 Malignant neoplasms of ovary ––– 2C73.0 Carcinomas of ovary ––– 2C73.1 Dysgerminoma of ovary ––– 2C73.2 Granulosa cell malignant tumour of ovary ––– 2C73.3 Malignant teratoma of ovary ––– 2C73.4 Serous cystadenoma, borderline malignancy of ovary ––– 2C73.5 Endodermal sinus tumour, unspecified site, female ––– 2C73.Y Other specified malignant neoplasms of the ovary ––– 2C73.Z Malignant neoplasms of ovary, unspecified –––– 2C73.00 Clear cell adenocarcinoma of ovary –––– 2C73.01 Endometrioid adenocarcinoma of ovary –––– 2C73.02 Low grade serous adenocarcinoma of ovary –––– 2C73.03 High grade serous adenocarcinoma of ovary –––– 2C73.04 Mucinous adenocarcinoma of ovary –––– 2C73.0Y Other specified carcinomas of ovary –––– 2C73.0Z Carcinomas of ovary, unspecified –– 2C74 Malignant neoplasms of fallopian tube ––– 2C74.0 Adenocarcinoma of fallopian tube ––– 2C74.Y Other specified malignant neoplasms of fallopian tube ––– 2C74.Z Malignant neoplasms of fallopian tube, unspecified –– 2C75 Malignant neoplasms of placenta ––– 2C75.0 Malignant trophoblastic neoplasms of placenta ––– 2C75.Y Other specified malignant neoplasms of placenta ––– 2C75.Z Malignant neoplasms of placenta, unspecified –– 2C76 Malignant neoplasms of corpus uteri ––– 2C76.0 Endometrial endometrioid adenocarcinoma ––– 2C76.1 Endometrial mucinous adenocarcinoma ––– 2C76.2 Endometrial clear cell adenocarcinoma ––– 2C76.3 Endometrial serous adenocarcinoma ––– 2C76.4 Endometrial mixed adenocarcinoma ––– 2C76.Y Other specified malignant neoplasms of corpus uteri ––– 2C76.Z Malignant neoplasms of corpus uteri, unspecified –––– 2C76.40 Endometrial squamous cell carcinoma –––– 2C76.41 Endometrial small cell carcinoma –––– 2C76.42 Endometrial undifferentiated carcinoma –––– 2C76.43 Carcinosarcoma of uterus –––– 2C76.4Z Endometrial mixed adenocarcinoma, unspecified –– 2C77 Malignant neoplasms of cervix uteri ––– 2C77.0 Squamous cell carcinoma of cervix uteri ––– 2C77.1 Adenocarcinoma of cervix uteri ––– 2C77.2 Adenosquamous carcinoma of cervix uteri ––– 2C77.3 Neuroendocrine carcinoma of cervix uteri ––– 2C77.Y Other specified malignant neoplasms of cervix uteri ––– 2C77.Z Malignant neoplasms of cervix uteri, unspecified –– 2C78 Malignant neoplasms of uterus, part not specified –– 2C79 Malignant neoplasm involving overlapping sites of female genital organs –– 2C7Y Other specified malignant neoplasms of female genital organs –– 2C7Z Malignant neoplasms of female genital organs, unspecified –– 2C80 Malignant neoplasms of testis ––– 2C80.2 Germ cell tumour of testis ––– 2C80.Y Other specified malignant neoplasms of testis ––– 2C80.Z Malignant neoplasms of testis, unspecified –– 2C81 Malignant neoplasms of penis ––– 2C81.0 Squamous cell carcinoma of penis ––– 2C81.1 Melanoma of penis ––– 2C81.Y Other specified malignant neoplasm of penis ––– 2C81.Z Malignant neoplasms of penis, unspecified –– 2C82 Malignant neoplasms of prostate ––– 2C82.0 Adenocarcinoma of prostate ––– 2C82.Y Other specified malignant neoplasms of prostate ––– 2C82.Z Malignant neoplasms of prostate, unspecified –– 2C83 Malignant neoplasms of scrotum ––– 2C83.0 Squamous cell carcinoma of scrotum ––– 2C83.Y Other specified malignant neoplasms of scrotum ––– 2C83.Z Malignant neoplasms of scrotum, unspecified –– 2C84 Malignant neoplasms of other specified male genital organs –– 2C8Z Malignant neoplasms of male genital organs, unspecified –– 2C90 Malignant neoplasms of kidney, except renal pelvis ––– 2C90.0 Renal cell carcinoma of kidney, except renal pelvis ––– 2C90.Y Other specified malignant neoplasms of kidney, except renal pelvis ––– 2C90.Z Malignant neoplasms of kidney, except renal pelvis, unspecified –– 2C91 Malignant neoplasms of renal pelvis ––– 2C91.0 Urothelial carcinoma of renal pelvis ––– 2C91.Y Other specified malignant neoplasms of renal pelvis ––– 2C91.Z Malignant neoplasms of renal pelvis, unspecified –– 2C92 Malignant neoplasms of ureter ––– 2C92.0 Urothelial carcinoma of ureter ––– 2C92.Y Other specified malignant neoplasms of ureter ––– 2C92.Z Malignant neoplasms of ureter, unspecified –– 2C93 Malignant neoplasms of urethra or paraurethral gland ––– 2C93.0 Adenocarcinoma of urethra or paraurethral gland ––– 2C93.1 Squamous cell carcinoma of urethra or paraurethral gland ––– 2C93.2 Urothelial carcinoma of urethra or paraurethral gland ––– 2C93.Y Other specified malignant neoplasms of urethra and paraurethral gland ––– 2C93.Z Malignant neoplasms of urethra or paraurethral gland, unspecified –– 2C94 Malignant neoplasms of bladder ––– 2C94.0 Adenocarcinoma of urinary bladder ––– 2C94.1 Squamous cell carcinoma of urinary bladder ––– 2C94.2 Urothelial carcinoma of bladder ––– 2C94.Y Other specified malignant neoplasms of bladder ––– 2C94.Z Malignant neoplasms of bladder, unspecified –– 2C95 Malignant neoplasm involving overlapping sites of urinary organs ––– 2C95.0 Adenocarcinoma involving overlapping sites of urinary organs ––– 2C95.1 Squamous cell carcinomas involving overlapping sites of urinary organs ––– 2C95.2 Urothelial carcinoma involving overlapping sites of urinary organs ––– 2C95.Y Other specified malignant neoplasms of overlapping lesion of urinary organs ––– 2C95.Z Malignant neoplasm involving overlapping sites of urinary organs, unspecified –– 2C9Y Other specified malignant neoplasms of urinary tract –– 2C9Z Malignant neoplasms of urinary tract, unspecified –– 2D00 Malignant neoplasm of conjunctiva ––– 2D00.0 Melanoma of conjunctiva ––– 2D00.1 Malignant neoplasm of caruncle ––– 2D00.2 Squamous cell carcinoma of conjunctiva ––– 2D00.Y Other specified malignant neoplasm of conjunctiva ––– 2D00.Z Malignant neoplasm of conjunctiva, unspecified –– 2D01 Malignant neoplasm of cornea ––– 2D01.0 Melanoma of cornea ––– 2D01.1 Squamous cell carcinoma of cornea ––– 2D01.Y Other specified malignant neoplasms of cornea ––– 2D01.Z Malignant neoplasm of cornea, unspecified –– 2D02 Malignant neoplasm of retina ––– 2D02.0 Adenocarcinoma of retinal pigment epithelium ––– 2D02.1 Malignant neuroepithelial tumours of retina ––– 2D02.2 Retinoblastoma ––– 2D02.Y Other specified malignant neoplasm of retina ––– 2D02.Z Malignant neoplasm of retina, unspecified –– 2D03 Malignant neoplasm of lacrimal apparatus ––– 2D03.0 Adenocarcinoma of the lacrimal apparatus ––– 2D03.1 Mucoepidermoid carcinoma of lacrimal apparatus ––– 2D03.2 Squamous cell carcinoma of the lacrimal apparatus ––– 2D03.Y Other specified malignant neoplasm of lacrimal apparatus ––– 2D03.Z Malignant neoplasm of lacrimal apparatus, unspecified –– 2D04 Malignant neoplasm of orbit –– 2D05 Malignant neoplasm of choroid ––– 2D05.0 Melanoma of choroid ––– 2D05.Y Other specified malignant neoplasm of choroid ––– 2D05.Z Malignant neoplasm of choroid, unspecified –– 2D06 Malignant neoplasm of ciliary body ––– 2D06.0 Adenocarcinoma of ciliary epithelium ––– 2D06.1 Malignant medulloepithelioma of ciliary body ––– 2D06.3 Malignant neuroepithelial tumours of ciliary body ––– 2D06.4 Melanoma of ciliary body ––– 2D06.Y Other specified malignant neoplasm of ciliary body ––– 2D06.Z Malignant neoplasm of ciliary body, unspecified –– 2D07 Malignant neoplasm of iris ––– 2D07.0 Adenocarcinoma of iris epithelium ––– 2D07.1 Malignant neuroepithelial tumours of iris ––– 2D07.2 Melanoma of iris ––– 2D07.Y Other specified malignant neoplasm of iris ––– 2D07.Z Malignant neoplasm of iris, unspecified –– 2D0Y Other specified malignant neoplasms of eye and ocular adnexa –– 2D0Z Malignant neoplasms of eye or ocular adnexa, unspecified –– 2D10 Malignant neoplasms of thyroid gland ––– 2D10.0 Follicular carcinoma of thyroid gland ––– 2D10.1 Papillary carcinoma of thyroid gland ––– 2D10.2 Poorly differentiated carcinoma of thyroid gland ––– 2D10.3 Undifferentiated carcinoma of thyroid gland ––– 2D10.4 Medullary carcinoma of thyroid gland ––– 2D10.Y Other specified malignant neoplasms of thyroid gland ––– 2D10.Z Malignant neoplasms of thyroid gland, unspecified –– 2D11 Malignant neoplasms of adrenal gland ––– 2D11.0 Adenocarcinoma of adrenal gland ––– 2D11.1 Malignant phaeochromocytoma of adrenal gland ––– 2D11.2 Neuroblastoma of adrenal gland ––– 2D11.Y Other specified malignant neoplasms of adrenal gland ––– 2D11.Z Malignant neoplasms of adrenal gland, unspecified –– 2D12 Malignant neoplasms of other endocrine glands or related structures ––– 2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type ––– 2D12.1 Adenocarcinoma of other endocrine glands or related structures ––– 2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures ––– 2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified –– 2D1Z Malignant neoplasms of endocrine glands, unspecified – 2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues – 2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
synonyms Neoplastic meningitis Malignant meningitis Carcinomatous meningitis Leukemic meningitis Lymphomatous meningitis
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com